文献速递物质与行为成瘾

阿片类成瘾的神经生物学:对立过程、高痛苦感与负强化

Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement.
PubMed 文献 · Biol Psychiatry · 2019-06-12

本文综述阿片类成瘾的神经生物学机制,提出阿片类药物通过劫持内源性阿片奖赏系统并招募脑应激与疼痛系统,产生痛觉过敏和高痛苦感(hyperkatifeia),从而通过负强化驱动强迫性用药行为。高痛苦感源于腹侧纹状体系统内失调及扩展杏仁核系统间应激系统招募,可延续至戒断后期并与条件性戒断学习交互促进复吸。

要点

  • 阿片类药物劫持奖赏系统并招募应激与疼痛系统,产生痛觉过敏和高痛苦感。
  • 高痛苦感定义为戒断时负性情绪或动机症状强度的增加,驱动负强化性用药。
  • 高痛苦感源于腹侧纹状体系统内失调和扩展杏仁核应激系统招募,可延续至戒断后期。

核心结论

  • 阿片类成瘾通过负强化过程驱动强迫性用药,高痛苦感是核心机制之一。
  • 高痛苦感源于奖赏系统系统内失调和脑应激系统系统间招募,并与条件性戒断学习交互促进复吸。

研究设计与样本

  • 本文为综述,基于动物模型和神经生物学证据总结阿片类成瘾机制。

主要发现

  • 动物模型中反复延长阿片类药物获取导致负性情绪样状态,表现为奖赏阈值升高、痛阈降低、焦虑样行为和烦躁样反应。
  • 高痛苦感可延续至戒断后期,并与条件性戒断学习交互促进强迫性阿片寻求行为的复吸。
  • 脑疼痛情绪系统的可塑性由急性过量用药触发,在反复戒断中敏化并持续至戒断后期。

临床怎么用

  • 临床应关注阿片类戒断中的负性情绪和疼痛症状(高痛苦感),其是负强化用药和复吸的重要驱动因素。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应量或统计阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Opioids are powerful drugs that usurp and overpower the reward function of endogenous opioids and engage dramatic tolerance and withdrawal via molecular and neurocircuitry neuroadaptations within the same reward system. However, they also engage the brain systems for stress and pain (somatic and emotional) while producing hyperalgesia and hyperkatifeia, which drive pronounced drug-seeking behavior via processes of negative reinforcement. Hyperkatifeia (derived from the Greek "katifeia" for dejection or negative emotional state) is defined as an increase in intensity of the constellation of negative emotional or motivational signs and symptoms of withdrawal from drugs of abuse. In animal models, repeated extended access to drugs or opioids results in negative emotion-like states, reflected by the elevation of reward thresholds, lower pain thresholds, anxiety-like behavior, and dysphoric-like responses. Such negative emotional states that drive negative reinforcement are hypothesized to derive from the within-system dysregulation of key neurochemical circuits that mediate incentive-salience and/or reward systems (dopamine, opioid peptides) in the ventral striatum and from the between-system recruitment of brain stress systems (corticotropin-releasing factor, dynorphin, norepinephrine, hypocretin, vasopressin, glucocorticoids, and neuroimmune factors) in the extended amygdala. Hyperkatifeia can extend into protracted abstinence and interact with learning processes in the form of conditioned withdrawal to facilitate relapse to compulsive-like drug seeking. Compelling evidence indicates that plasticity in the brain pain emotional systems is triggered by acute excessive drug intake and becomes sensitized during the development of compulsive drug taking with repeated withdrawal. It then persists into protracted abstinence and contributes to the development and persistence of compulsive opioid-seeking behavior.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Koob GF. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement. Biol Psychiatry. 2019. PMID: 31400808. doi:10.1016/j.biopsych.2019.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。